305 related articles for article (PubMed ID: 29051551)
1. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice.
Voit A; Patel V; Pachon R; Shah V; Bakhutma M; Kohlbrenner E; McArdle JJ; Dell'Italia LJ; Mendell JR; Xie LH; Hajjar RJ; Duan D; Fraidenraich D; Babu GJ
Nat Commun; 2017 Oct; 8(1):1068. PubMed ID: 29051551
[TBL] [Abstract][Full Text] [Related]
2. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
[TBL] [Abstract][Full Text] [Related]
3. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in
Mareedu S; Pachon R; Thilagavathi J; Fefelova N; Balakrishnan R; Niranjan N; Xie LH; Babu GJ
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H200-H210. PubMed ID: 33216625
[TBL] [Abstract][Full Text] [Related]
4. Improved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice.
Mareedu S; Fefelova N; Galindo CL; Prakash G; Mukai R; Sadoshima J; Xie LH; Babu GJ
JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38564291
[TBL] [Abstract][Full Text] [Related]
5. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.
Fajardo VA; Chambers PJ; Juracic ES; Rietze BA; Gamu D; Bellissimo C; Kwon F; Quadrilatero J; Russell Tupling A
Hum Mol Genet; 2018 Dec; 27(23):4094-4102. PubMed ID: 30137316
[TBL] [Abstract][Full Text] [Related]
6. Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy.
Niranjan N; Mareedu S; Tian Y; Kodippili K; Fefelova N; Voit A; Xie LH; Duan D; Babu GJ
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C813-C824. PubMed ID: 31365291
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
8. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
[TBL] [Abstract][Full Text] [Related]
9. Reducing sarcolipin expression improves muscle metabolism in
Balakrishnan R; Mareedu S; Babu GJ
Am J Physiol Cell Physiol; 2022 Feb; 322(2):C260-C274. PubMed ID: 34986021
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice.
Kunert-Keil CH; Gredes T; Lucke S; Botzenhart U; Dominiak M; Gedrange T
J Physiol Pharmacol; 2014 Apr; 65(2):317-24. PubMed ID: 24781740
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
12. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
13. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
14. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.
Wasala NB; Yue Y; Lostal W; Wasala LP; Niranjan N; Hajjar RJ; Babu GJ; Duan D
Mol Ther; 2020 Mar; 28(3):845-854. PubMed ID: 31981493
[TBL] [Abstract][Full Text] [Related]
15. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
16. Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.
Strimpakos G; Corbi N; Pisani C; Di Certo MG; Onori A; Luvisetto S; Severini C; Gabanella F; Monaco L; Mattei E; Passananti C
J Cell Physiol; 2014 Sep; 229(9):1283-91. PubMed ID: 24469912
[TBL] [Abstract][Full Text] [Related]
17. Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.
Wasala NB; Yue Y; Vance J; Duan D
J Mol Cell Cardiol; 2017 Jan; 102():45-52. PubMed ID: 27908661
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
20. Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy.
Schneider JS; Shanmugam M; Gonzalez JP; Lopez H; Gordan R; Fraidenraich D; Babu GJ
J Muscle Res Cell Motil; 2013 Dec; 34(5-6):349-56. PubMed ID: 23748997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
